Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 9/20 | 0.37 |
| ▸ | CA2 | P00918 | 9/20 | 0.37 |
| ▸ | CA9 | Q16790 | 9/20 | 0.37 |
| ▸ | CA12 | O43570 | 4/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.36 |
| ▸ | LPAR2 | Q9HBW0 | 5/20 | 0.36 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.36 |
| ▸ | CA3 | P07451 | 2/20 | 0.36 |
| ▸ | CA4 | P22748 | 2/20 | 0.36 |
| ▸ | CA6 | P23280 | 2/20 | 0.36 |
| ▸ | CA5A | P35218 | 2/20 | 0.36 |
| ▸ | CA7 | P43166 | 2/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16311962 | 0.97 | THRB (0.44) | THRBTSHRCA1CA2CA9 | |
| SCHEMBL127022 | 0.97 | THRB (0.44) | THRBTSHRCA1CA2CA9 | |
| SCHEMBL16311963 | 0.97 | THRB (0.44) | THRBTSHRCA1CA2CA9 | |
| SCHEMBL4505591 | 0.97 | THRB (0.44) | THRBTSHRCA1CA2CA9 | |
| SCHEMBL2647917 | 0.97 | THRB (0.44) | THRBTSHRCA1CA2CA9 | |
| SCHEMBL24829886 | 0.97 | THRB (0.44) | THRBTSHRCA1CA2CA9 | |
| SCHEMBL278721 | 0.97 | THRB (0.44) | THRBTSHRCA1CA2CA9 | |
| SCHEMBL4493956 | 0.97 | THRB (0.44) | THRBTSHRCA1CA2CA9 | |
| SCHEMBL16311961 | 0.97 | THRB (0.44) | THRBTSHRCA1CA2CA9 | |
| SCHEMBL2276634 | 0.97 | THRB (0.44) | THRBTSHRCA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0963367-B1 | PROCESS FOR PREPARING ALKYL ETHERS AND MIXTURES THEREOF | FORTUM OIL & GAS OY (FI) | 2002-07-24 | — | — | EP | claimed |
| EP-0249139-A2 | Resist compositions and use | MicroSi, Inc. (a Delaware corporation) (US) | 1987-12-16 | — | — | EP | claimed |
| US-12577185-B2 | Solvent drying solution and processes therfor | AQUAFORTUS TECHNOLOGIES LIMITED (NZ) | 2026-03-17 | — | — | US | disclosed |
| US-20240262772-A1 | A SOLVENT DRYING SOLUTION AND PROCESSES THERFOR | AQUAFORTUS TECHNOLOGIES LIMITED (NZ) | 2024-08-08 | — | — | US | disclosed |
| US-20240239787-A1 | COMPOUNDS FOR USE IN THE TREATMENT OF CANCER | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2024-07-18 | — | — | US | disclosed |
| CN-117924548-A | Catalyst component for olefin polymerization, preparation method, catalyst system and olefin polymerization method | 中国石油化工股份有限公司 | 2024-04-26 | — | — | CN | disclosed |
| US-20240018156-A1 | SPIROCYCLIC COMPOUNDS | C4 THERAPEUTICS, INC. (US) | 2024-01-18 | — | — | US | disclosed |
| US-20230357180-A1 | DEGRADERS AND DEGRONS FOR TARGETED PROTEIN DEGRADATION | C4 THERAPEUTICS, INC. (US) | 2023-11-09 | — | — | US | disclosed |
| WO-2023171325-A1 | METHOD FOR PRODUCING ALKENE | 株式会社クレハ | 2023-09-14 | — | — | WO | disclosed |
| US-20230286833-A1 | A SALT RECOVERY SOLUTION AND PROCESSES OF USE THEREOF | AQUAFORTUS TECHNOLOGIES LIMITED (NZ) | 2023-09-14 | — | — | US | disclosed |
| WO-2023171326-A1 | METHOD FOR PRODUCING ALKENE | 株式会社クレハ | 2023-09-14 | — | — | WO | disclosed |
| US-5401429-A | Fractional distillation with hydrocarbons, perfluoroalkyl morpholine | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1995-03-28 | — | — | US | disclosed |
| WO-1994023091-A1 | AZEOTROPIC COMPOSITIONS CONTAINING PERFLUORINATED CYCLOAMINOETHER | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1994-10-13 | — | — | WO | disclosed |
| EP-0609058-A2 | Hexahydronaphthalene ester derivatives, their preparation and their therapeutic uses | SANKYO COMPANY LIMITED (JP) | 1994-08-03 | — | — | EP | disclosed |
| EP-0284005-B1 | METHOD OF PRODUCTION OF POLYOLEFINS | IDEMITSU PETROCHEMICAL CO. LTD. (JP) | 1991-12-18 | — | — | EP | disclosed |
| US-5068490-A | Alkyl tert-butyl ether boron trifluoride complex as a catalyst | AMOCO CORPORATION (US) | 1991-11-26 | — | — | US | disclosed |
| US-4981930-A | POLYMERIZATION CATALYSTS | IDEMITSU PETROCHEMICAL COMPANY LIMITED (JP) | 1991-01-01 | — | — | US | disclosed |
| EP-0284005-A2 | Method of production of polyolefins | IDEMITSU PETROCHEMICAL CO. LTD. (JP) | 1988-09-28 | — | — | EP | disclosed |
| EP-0054805-B1 | PROCESS FOR PREPARING TERTIARY OLEFINES | EC ERDÖLCHEMIE GMBH (DE) | 1985-07-03 | — | — | EP | disclosed |
| EP-0054805-A1 | Process for preparing tertiary olefines | EC ERDÖLCHEMIE GMBH (DE) | 1982-06-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577185-B2 | Solvent drying solution and processes therfor | CASP7, CERT1, CA7 | THRB 803/4885TSHR 2258/4885CA1 68/4885 |
| US-20240018156-A1 | SPIROCYCLIC COMPOUNDS | CRBN, XIAP, RBX1 | THRB 2256/4885TSHR 3600/4885CA1 1738/4885 |
| US-20240262772-A1 | A SOLVENT DRYING SOLUTION AND PROCESSES THERFOR | AQP1, WFS1, AQP4 | THRB 2424/4885TSHR 3470/4885CA1 439/4885 |
| US-20230357180-A1 | DEGRADERS AND DEGRONS FOR TARGETED PROTEIN DEGRADATION | STUB1, MDM2, USP30 | THRB 2605/4885TSHR 1595/4885CA1 4649/4885 |
| US-20240239787-A1 | COMPOUNDS FOR USE IN THE TREATMENT OF CANCER | BRIX1, TP53, XPOT | THRB 2880/4885TSHR 2641/4885CA1 2621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.